These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4012358)

  • 1. The dominant firm in health insurance.
    Goldberg LG; Greenberg W
    Soc Sci Med; 1985; 20(7):719-24. PubMed ID: 4012358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition between non-profit and for-profit health insurers.
    Adamache KW; Sloan FA
    J Health Econ; 1983 Dec; 2(3):225-43. PubMed ID: 10264797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of Blue Cross in a competitive marketplace.
    Greenberg W
    Bus Health; 1986 Nov; 4(1):44, 46-7. PubMed ID: 10278818
    [No Abstract]   [Full Text] [Related]  

  • 4. Market share and the illusion of power. Can Blue Cross force hospitals to discount?
    Staten M; Dunkelberg W; Umbeck J
    J Health Econ; 1987 Mar; 6(1):43-58. PubMed ID: 10282729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blue Cross market share, economies of scale, and cost containment effort.
    Feldman R; Greenberg W
    Health Serv Res; 1981; 16(2):176-83. PubMed ID: 7263273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corporate transformation of medicine in Minnesota. The view from Eagan: an interview with Minnesota Blue Cross-Blue Shield officials. Seventeenth in a series. Interview by Richard L. Reece.
    Minn Med; 1986 Mar; 69(3):115-23. PubMed ID: 3504222
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of Blue Cross and Blue Shield in the future U.S. health care system.
    Griffith JR
    Inquiry; 1983; 20(1):12-9. PubMed ID: 6219942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blue Cross-Blue Shield in the future.
    Tresnowski BR
    Bus Health; 1986 Nov; 4(1):48-9. PubMed ID: 10278819
    [No Abstract]   [Full Text] [Related]  

  • 9. 21st century tonic for Blue Cross & Blue Shield. Part II.
    R I Med J (1976); 1981 Feb; 64(2):73-8. PubMed ID: 6939051
    [No Abstract]   [Full Text] [Related]  

  • 10. Guiding Blue Cross and Blue Shield through troubled waters. Interview by Emily Friedman.
    Tresnowski B
    Hospitals; 1982 Dec; 56(24):91-6. PubMed ID: 7141441
    [No Abstract]   [Full Text] [Related]  

  • 11. What makes the Blue tick?
    Powsner R
    Mich Med; 1982 Nov; 81(51):638-40. PubMed ID: 7176966
    [No Abstract]   [Full Text] [Related]  

  • 12. The competitive response of Blue Cross to the health maintenance organization.
    Goldberg LG; Greenberg W
    Econ Inq; 1980 Jan; 18(1):55-68. PubMed ID: 10245692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market power, monopsony, and health insurance markets.
    Pauly MV
    J Health Econ; 1988 Jun; 7(2):111-28. PubMed ID: 10288954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new health care: the Blue Cross and Blue Shield organization's response to change.
    Kaplan SM
    J Med Pract Manage; 1985 Oct; 1(2):110-3. PubMed ID: 10281822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Blue Cross.
    Schonbrun M
    J Health Polit Policy Law; 1977; 2(3):319-34. PubMed ID: 591701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eastern Blue Cross pacts tough: survey.
    O'Tousa M
    Hospitals; 1982 Jul; 56(13):31-2. PubMed ID: 7084898
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection of health insurance by an employee group in Northern California.
    Piontkowski D; Butler LH
    Am J Public Health; 1980 Mar; 70(3):274-6. PubMed ID: 7356092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blues' new policies boost cost sharing.
    Staver S
    Am Med News; 1982 Jul; 25(27):1, 8. PubMed ID: 10324210
    [No Abstract]   [Full Text] [Related]  

  • 19. Blues chief predicts rosier future for plans.
    Kuntz EF
    Mod Healthc; 1982 Mar; 12(3):17, 22. PubMed ID: 10254602
    [No Abstract]   [Full Text] [Related]  

  • 20. Bounceback: Blues thrive as markets cool toward HMOs.
    Cunningham R; Sherlock DB
    Health Aff (Millwood); 2002; 21(1):24-38. PubMed ID: 11900082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.